Form D · Biotechnology
Telos Biotech Inc.
Dallas, TX · CIK 0001815708
Offering snapshot reported Dec 12, 2025 · SEC filing
- Reported sold
- $725K Offering amount: $2.25M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 12, 2025 | Initial | $724,999 | No comparison | 4 | SEC filing |
| Jul 10, 2020 | Initial | $700,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-566723
Stated "Total Offering Amount" and "Total Remaining to be Sold" each include the aggregate consideration the issuer may receive in the event the warrants offered are exercised for cash. Currently no warrants have been issued or exercised.
Source: Form D, filed Dec 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sebastian Aguiar Brunemeier | Director |
| James G. Peyer | Director, Executive, Promoter |
| Mohammad Ehsan Sayed | Director, Executive |
| Jerry William Shay | Executive |
| Enzo Tedone | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3060 Pegasus Park Dr Building 6
Dallas, TX, 75247
Dallas, TX, 75247